Sino Biopharmaceutical Ltd
OTC:SBHMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sino Biopharmaceutical Ltd
OTC:SBHMY
|
HK |
|
Gattaca PLC
LSE:GATC
|
UK |
Wall Street
Price Targets
SBHMY Price Targets Summary
Sino Biopharmaceutical Ltd
According to Wall Street analysts, the average 1-year price target for
SBHMY
is 23.94 USD
with a low forecast of 15.21 USD and a high forecast of 32.16 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SBHMY's stock price target?
Price Target
23.94
USD
According to Wall Street analysts, the average 1-year price target for
SBHMY
is 23.94 USD
with a low forecast of 15.21 USD and a high forecast of 32.16 USD.
What is Sino Biopharmaceutical Ltd's Revenue forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's revenue is
14%.
The projected
CAGR
for the next 3 years is
13%.
What is Sino Biopharmaceutical Ltd's Operating Income forecast?
Projected CAGR
18%
For the last 14 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's operating income is
16%.
The projected
CAGR
for the next 3 years is
18%.
What is Sino Biopharmaceutical Ltd's Net Income forecast?
Projected CAGR
56%
For the last 14 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's net income is
14%.
The projected
CAGR
for the next 2 years is
56%.
